Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.47% | 18.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.47% | 18.75% | |||
| Cost of Revenue | 15.55% | 16.29% | |||
| Gross Profit | 6.35% | 23.96% | |||
| SG&A Expenses | 2.45% | 10.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.27% | 14.72% | |||
| Operating Income | 14.08% | 64.39% | |||
| Income Before Tax | 513.64% | -49.71% | |||
| Income Tax Expenses | 432.85% | -37.50% | |||
| Earnings from Continuing Operations | 555.57% | -54.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 555.57% | -54.34% | |||
| EBIT | 14.08% | 64.39% | |||
| EBITDA | 12.81% | 53.68% | |||
| EPS Basic | 555.60% | -54.36% | |||
| Normalized Basic EPS | 154.97% | 7.55% | |||
| EPS Diluted | 548.85% | -53.76% | |||
| Normalized Diluted EPS | 155.06% | 7.22% | |||
| Average Basic Shares Outstanding | 0.04% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.33% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.85% | 1.19% | |||